QS Investors’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
$6.41M Hold
35,716
0.08% 196
2021
Q1
$5.98M Sell
35,716
-197
-0.5% -$33K 0.07% 211
2020
Q4
$5.45M Sell
35,913
-69
-0.2% -$10.5K 0.07% 213
2020
Q3
$3.64M Buy
35,982
+17,900
+99% +$1.81M 0.05% 257
2020
Q2
$2.19M Buy
18,082
+15,665
+648% +$1.9M 0.03% 456
2020
Q1
$230K Hold
2,417
﹤0.01% 1025
2019
Q4
$212K Buy
2,417
+270
+13% +$23.7K ﹤0.01% 1173
2019
Q3
$172K Sell
2,147
-808
-27% -$64.7K ﹤0.01% 1239
2019
Q2
$231K Sell
2,955
-35,400
-92% -$2.77M ﹤0.01% 1182
2019
Q1
$4.5M Sell
38,355
-5
-0% -$587 0.05% 299
2018
Q4
$4.18M Buy
38,360
+3,467
+10% +$378K 0.05% 276
2018
Q3
$4.46M Buy
34,893
+30,658
+724% +$3.92M 0.04% 318
2018
Q2
$479K Hold
4,235
﹤0.01% 958
2018
Q1
$476K Buy
4,235
+215
+5% +$24.2K ﹤0.01% 943
2017
Q4
$595K Hold
4,020
0.01% 904
2017
Q3
$471K Hold
4,020
﹤0.01% 974
2017
Q2
$522K Sell
4,020
-13,104
-77% -$1.7M ﹤0.01% 921
2017
Q1
$2.32M Sell
17,124
-74,100
-81% -$10M 0.02% 552
2016
Q4
$13.1M Buy
91,224
+31,980
+54% +$4.59M 0.11% 140
2016
Q3
$7M Buy
59,244
+19,700
+50% +$2.33M 0.05% 278
2016
Q2
$4.19M Buy
39,544
+26,500
+203% +$2.81M 0.04% 440
2016
Q1
$1.45M Buy
13,044
+2,093
+19% +$233K 0.01% 697
2015
Q4
$1.72M Sell
10,951
-1,261
-10% -$197K 0.02% 695
2015
Q3
$1.6M Sell
12,212
-8,600
-41% -$1.13M 0.02% 677
2015
Q2
$3.62M Sell
20,812
-7,854
-27% -$1.37M 0.04% 465
2015
Q1
$4.94M Hold
28,666
0.06% 379
2014
Q4
$3.71M Buy
28,666
+15,166
+112% +$1.96M 0.04% 435
2014
Q3
$1.74M Sell
13,500
-81,500
-86% -$10.5M 0.05% 259
2014
Q2
$8.41M Buy
95,000
+53,400
+128% +$4.73M 0.23% 116
2014
Q1
$3.91M Buy
41,600
+38,300
+1,161% +$3.6M 0.12% 173
2013
Q4
$373K Sell
3,300
-1,300
-28% -$147K 0.01% 469
2013
Q3
$363K Sell
4,600
-41,800
-90% -$3.3M 0.02% 473
2013
Q2
$3.05M Buy
+46,400
New +$3.05M 0.11% 234